Reneo Pharmaceuticals (RPHM) director Phillips received 15,300 Stock Option (right to buy)

Insider transactions reported

Andrew John Phillips (director at Reneo Pharmaceuticals Inc., RPHM) reported that they received 15,300 Stock Option (right to buy) on Oct 4, 2024.

Reporting person

Phillips Andrew John

Options and other derivatives

Holdings before and after

• Stock Option (right to buy): 0 to 15,300 direct

Footnotes from the filing

1. 1. 1/36th of the shares subject to the option shall vest on November 4, 2024 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ